DHR Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Danaher Corp - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 247.51 USD -0.3%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast DHR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DHR is 276.82 USD with a low forecast of 222.2 USD and a high forecast of 311.85 USD.

DHR Lowest Forecast

Wall Street Target

DHR Average Forecast

Wall Street Target

DHR Highest Forecast

Wall Street Target

10% Downside

12% Upside

26% Upside

The latest public price target was made on Apr 23, 2024 by Justin Bowers from Deutsche Bank , who expects DHR stock to rise by 9% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Justin Bowers Deutsche Bank	270 USD Upside 9%	1 week ago Apr 23, 2024	Deutsche Bank on Danaher (DHR): 'We expect strength in DHR stock' StreetInsider
Rajesh Kumar HSBC	280 USD Upside 13%	2 weeks ago Apr 17, 2024	HSBC upgrades Danaher to Buy on biotech funding recovery TheFly
Paul Knight Loop Capital Markets	300 USD Upside 21%	7 months ago Sep 27, 2023	Danaher Bears The Brunt Of Macro Woes: Analyst Flags Lower Demand, Reduced Funding & Weakness In China Benzinga

Price Target	270 USD
Upside/Downside	9%

Price Target	280 USD
Upside/Downside	13%

Price Target	300 USD
Upside/Downside	21%

Illumina Inc

33% Upside

Agilent Technologies Inc

9% Upside

Ergomed PLC

7% Upside

Fortrea Holdings Inc

10% Upside

Illumina Inc

33% Upside

Agilent Technologies Inc

9% Upside

Ergomed PLC

7% Upside

Fortrea Holdings Inc

10% Upside

MaxCyte Inc

158% Upside

West Pharmaceutical Services Inc

13% Upside

Repligen Corp

24% Upside

Biotoxtech Co Ltd

161% Upside

Revenue
Forecast

For the last 8 years the compound annual growth rate for Danaher Corp's revenue is 7%. The projected CAGR for the next 3 years is 6%.

7%

6%

-15%

What are analyst estimates?

Operating Income
Forecast

For the last 8 years the compound annual growth rate for Danaher Corp's operating income is 11%. The projected CAGR for the next 3 years is 17%.

11%

17%

-24%

What are analyst estimates?

Net Income
Forecast

For the last 8 years the compound annual growth rate for Danaher Corp's net income is 4%. The projected CAGR for the next 3 years is 15%.

4%

15%

-15%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for DHR is 276.82 USD with a low forecast of 222.2 USD and a high forecast of 311.85 USD.

For the last 8 years the compound annual growth rate for Danaher Corp's revenue is 7%. The projected CAGR for the next 3 years is 6%.

For the last 8 years the compound annual growth rate for Danaher Corp's operating income is 11%. The projected CAGR for the next 3 years is 17%.

For the last 8 years the compound annual growth rate for Danaher Corp's net income is 4%. The projected CAGR for the next 3 years is 15%.

Join more than 134,800+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.